Michael Leveridge

1.8k total citations
60 papers, 1.3k citations indexed

About

Michael Leveridge is a scholar working on Pulmonary and Respiratory Medicine, Surgery and General Health Professions. According to data from OpenAlex, Michael Leveridge has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 13 papers in General Health Professions. Recurrent topics in Michael Leveridge's work include Renal cell carcinoma treatment (13 papers), Renal and related cancers (10 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Michael Leveridge is often cited by papers focused on Renal cell carcinoma treatment (13 papers), Renal and related cancers (10 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Michael Leveridge collaborates with scholars based in Canada, United States and Australia. Michael Leveridge's co-authors include Antonio Finelli, Michael A.S. Jewett, John R. Kachura, Hannah Chung, Daniel Shiff, Kimberly A. Fernandes, Andrew Evans, Rano Matta, D. Robert Siemens and Henry H. Woo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Michael Leveridge

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Leveridge Canada 19 583 353 320 303 254 60 1.3k
Edward Christopher Dee United States 20 343 0.6× 100 0.3× 222 0.7× 138 0.5× 169 0.7× 216 1.7k
Daniel W. Golden United States 23 424 0.7× 200 0.6× 229 0.7× 74 0.2× 274 1.1× 145 2.0k
Mina S. Sedrak United States 21 417 0.7× 116 0.3× 326 1.0× 173 0.6× 177 0.7× 104 2.0k
Biniam Kidane Canada 20 578 1.0× 109 0.3× 92 0.3× 114 0.4× 601 2.4× 112 1.4k
Anne-Marie Meyer United States 17 399 0.7× 138 0.4× 177 0.6× 35 0.1× 165 0.6× 24 981
Jan Norum Norway 25 502 0.9× 104 0.3× 256 0.8× 95 0.3× 246 1.0× 129 1.9k
Katharina Böehm Germany 20 920 1.6× 265 0.8× 117 0.4× 29 0.1× 300 1.2× 111 1.5k
Lewis E. Foxhall United States 15 280 0.5× 196 0.6× 144 0.5× 43 0.1× 165 0.6× 29 1.5k
William R. Carpenter United States 27 774 1.3× 135 0.4× 345 1.1× 80 0.3× 392 1.5× 100 2.7k
Niraj J. Gusani United States 29 725 1.2× 202 0.6× 118 0.4× 128 0.4× 1.2k 4.5× 107 2.4k

Countries citing papers authored by Michael Leveridge

Since Specialization
Citations

This map shows the geographic impact of Michael Leveridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Leveridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Leveridge more than expected).

Fields of papers citing papers by Michael Leveridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Leveridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Leveridge. The network helps show where Michael Leveridge may publish in the future.

Co-authorship network of co-authors of Michael Leveridge

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Leveridge. A scholar is included among the top collaborators of Michael Leveridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Leveridge. Michael Leveridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleshner, Neil, Rui Bernardino, Katherine Lajkosz, et al.. (2024). A randomized, double-blind, placebo-controlled trial of metformin in reducing progression among men on expectant management for low-risk prostate cancer: The MAST (Metformin Active Surveillance Trial) study.. Journal of Clinical Oncology. 42(17_suppl). LBA5002–LBA5002. 7 indexed citations
2.
Richard, Patrick O., Philippe D. Violette, Bimal Bhindi, et al.. (2023). 2023 UPDATE – Canadian Urological Association guideline: Management of cystic renal lesions. Canadian Urological Association Journal. 17(6). 162–74. 4 indexed citations
3.
Leveridge, Michael, et al.. (2023). Priapism in a Patient with Rectal Adenocarcinoma. SHILAP Revista de lepidopterología. 11(1). 34–34. 2 indexed citations
4.
Hopman, Wilma M., et al.. (2020). Physicians' Earnings Do Not Affect Their Online Ratings. Frontiers in Public Health. 8. 300–300. 3 indexed citations
5.
Thangasamy, Isaac, Stacy Loeb, Niranjan Sathianathen, et al.. (2019). Evaluating the Effectiveness of an Online Journal Club: Experience from the International Urology Journal Club. European Urology Focus. 7(2). 482–488. 19 indexed citations
6.
Kassouf, Wassim, Darrel Drachenberg, Adrian Fairey, et al.. (2018). Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma. Canadian Urological Association Journal. 12(8). 231–238. 10 indexed citations
7.
Karim, Safiya, Xuejiao Wei, Michael Leveridge, et al.. (2018). Delivery of chemotherapy for testicular cancer in routine practice: A population-based study. Urologic Oncology Seminars and Original Investigations. 37(3). 183.e17–183.e24. 3 indexed citations
8.
Gregg, Richard, Francisco Vera-Badillo, Christopher M. Booth, et al.. (2018). Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 128. 58–64. 21 indexed citations
9.
Richard, Patrick O., Philippe D. Violette, Michael A.S. Jewett, et al.. (2017). CUA guideline on the management of cystic renal lesions. Canadian Urological Association Journal. 11(3-4). 66–66. 27 indexed citations
10.
Yip, Desmond, et al.. (2017). The Patterns of Practice and Outcomes of Penile Cancer in Ontario. Clinical Oncology. 29(4). 239–247. 4 indexed citations
11.
Davidson, Christopher, et al.. (2017). Case: Testicular oligometastasis from prostate cancer — Report of rare isolated recurrence after radiotherapy and intermittent androgen-deprivation therapy. Canadian Urological Association Journal. 12(1). E31–3. 2 indexed citations
12.
Leveridge, Michael, et al.. (2016). An analysis of the readability of patient information materials for common urological conditions. Canadian Urological Association Journal. 10(5-6). 167–167. 23 indexed citations
13.
Izard, Jason, D. Robert Siemens, William J. Mackillop, et al.. (2015). Outcomes of squamous histology in bladder cancer: A population-based study. Urologic Oncology Seminars and Original Investigations. 33(10). 425.e7–425.e13. 46 indexed citations
14.
Gandaglia, Giorgio, Freddie Bray, Matthew R. Cooperberg, et al.. (2015). Prostate Cancer Registries: Current Status and Future Directions. European Urology. 69(6). 998–1012. 52 indexed citations
15.
Leveridge, Michael, D. Robert Siemens, William J. Mackillop, et al.. (2015). Radical Cystectomy and Adjuvant Chemotherapy for Bladder Cancer in the Elderly: A Population-based Study. Urology. 85(4). 791–798. 35 indexed citations
16.
Leveridge, Michael, D. Robert Siemens, & Christopher Morash. (2013). What next? Managing lymph nodes in men with penile cancer. Canadian Urological Association Journal. 2(5). 525–525. 4 indexed citations
17.
Leveridge, Michael, et al.. (2013). Health advocacy training in urology: a Canadian survey on. Canadian Urological Association Journal. 1(4). 363–363. 22 indexed citations
18.
Kurban, Ghada, Brenda L. Gallie, Michael Leveridge, et al.. (2011). Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: Observations on DNA, RNA, protein extractions and VHL mutation detection. Pathology - Research and Practice. 208(1). 22–31. 11 indexed citations
19.
Leveridge, Michael & Michael A.S. Jewett. (2011). Recent developments in kidney cancer. Canadian Urological Association Journal. 5(3). 195–203. 6 indexed citations
20.
Leveridge, Michael, Peter J. Boström, George Koulouris, Antonio Finelli, & Nathan Lawrentschuk. (2010). Imaging renal cell carcinoma with ultrasonography, CT and MRI. Nature Reviews Urology. 7(6). 311–325. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Christopher Dee Breakdown of academic impact, for papers by Daniel W. Golden Breakdown of academic impact, for papers by Mina S. Sedrak Breakdown of academic impact, for papers by Biniam Kidane Breakdown of academic impact, for papers by Anne-Marie Meyer Breakdown of academic impact, for papers by Jan Norum Breakdown of academic impact, for papers by Katharina Böehm Breakdown of academic impact, for papers by Lewis E. Foxhall Breakdown of academic impact, for papers by William R. Carpenter Breakdown of academic impact, for papers by Niraj J. Gusani
Rankless by CCL
2026